自发冠状动脉剖析:相关心血管风险的病例系列和审查
Eyad Ahmed1, Swetha Balaji, Atul Prakash
1From the Department of Medicine, New York Medical College, St. Mary's General Hospital and St. Clare's Health, Passaic, NJ.
Cardiology in review
|December 23, 2025
概括
自发冠状动脉解剖 (SCAD) 在年轻女性中越来越多地被认可. 这项研究发现,SCAD经常与传统的心血管风险因素相关,而不仅仅是纤维肌力发育不良,并且往往对保守的管理有很好的反应.
科学领域:
- 心脏病学 心脏病学
- 血管生物学 血管生物学
背景情况:
- 自发冠状动脉解剖 (SCAD) 是急性冠状动脉综合征 (ACS) 的未被确诊的原因,特别是在年轻女性中.
- 从历史上看,SCAD被认为是罕见的,主要与纤维肌力发育不良或结缔组织疾病有关.
- 新出现的证据表明,SCAD可能与传统的心血管风险因素有关.
研究的目的:
- 在被诊断为SCAD的患者中调查心血管风险因素的患病率.
- 确定SCAD中潜在的促成因素和疾病机制.
- 评估SCAD患者的管理策略和结果.
主要方法:
- 在五年内,三所机构连续13名SCAD患者的回顾性分析.
- 对患者人口统计,心血管风险因素和诊断结果的审查.
- 对治疗方法和临床结果的评估.
主要成果:
- 在胸痛的心脏导管治疗中,SCAD占0.5%.
- 患者的平均年龄为49.3岁,其中84%为女性.
- 相关的危险因素包括高脂血症 (61%),高血压 (46%) 和糖尿病前期 (8%).
- 在38%的患者中观察到升高的D-二聚物水平;炎症标志物不常见.
- 没有发现纤维肌力发育不良或结缔组织疾病的病例.
- 大多数患者通过双重抗血小板疗法进行了保守的治疗,取得了很好的结果.
结论:
- 在这个队列中,SCAD经常与传统的心血管风险因素相关,这表明内皮细胞脆弱性发挥了作用.
- 升高的D-二次体可能表明SCAD中的疾病活性.
- 对大多数SCAD患者来说,双重抗血小板治疗的保守管理是有效的.
- 提高临床意识对于及时诊断和管理SCAD至关重要.
相关概念视频
01:30Coronary Artery Disease I: Introduction
846
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
846
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
324
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
324
01:26Coronary Artery Disease II: Pathophysiology
336
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
336
01:30Coronary Artery Disease III: Clinical Manifestations
299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
01:27Coronary Artery Disease V: Interprofessional Care
203
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
203
01:26Coronary Artery Disease IV: Preventive Measures
564
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
564